siRNA: Mechanism of action, challenges, and therapeutic approaches
W Alshaer, H Zureigat, A Al Karaki, A Al-Kadash… - European journal of …, 2021 - Elsevier
Owing to specific and compelling gene silencing, RNA interference (RNAi) is expected to
become an essential approach in treating a variety of infectious, hemato-oncological …
become an essential approach in treating a variety of infectious, hemato-oncological …
On-Line Analysis of Exhaled Breath: Focus Review
On-line analysis of exhaled breath offers insight into a person's metabolism without the need
for sample preparation or sample collection. Due to its noninvasive nature and the possibility …
for sample preparation or sample collection. Due to its noninvasive nature and the possibility …
The dual role of myeloperoxidase in immune response
J Arnhold - International Journal of Molecular Sciences, 2020 - mdpi.com
The heme protein myeloperoxidase (MPO) is a major constituent of neutrophils. As a key
mediator of the innate immune system, neutrophils are rapidly recruited to inflammatory …
mediator of the innate immune system, neutrophils are rapidly recruited to inflammatory …
New insights into the role of NLRP3 inflammasome in pathogenesis and treatment of chronic obstructive pulmonary disease
J Zhang, Q Xu, W Sun, X Zhou, D Fu… - Journal of inflammation …, 2021 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease
characterized by chronic airway obstruction and emphysema. Accumulating studies have …
characterized by chronic airway obstruction and emphysema. Accumulating studies have …
Early diagnosis and real-time monitoring of regional lung function changes to prevent chronic obstructive pulmonary disease progression to severe emphysema
T Jung, N Vij - Journal of Clinical Medicine, 2021 - mdpi.com
First-and second-hand exposure to smoke or air pollutants is the primary cause of chronic
obstructive pulmonary disease (COPD) pathogenesis, where genetic and age-related …
obstructive pulmonary disease (COPD) pathogenesis, where genetic and age-related …
Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease
KA Serban, KA Pratte, C Strange, RA Sandhaus… - …, 2022 - thelancet.com
Summary Background Alpha-1 Antitrypsin (AAT) deficiency (AATD), the most common
genetic cause of emphysema presents with unexplained phenotypic heterogeneity in …
genetic cause of emphysema presents with unexplained phenotypic heterogeneity in …
Proteases and their inhibitors in chronic obstructive pulmonary disease
In the context of respiratory disease, chronic obstructive pulmonary disease (COPD) is the
leading cause of mortality worldwide. Despite much development in the area of drug …
leading cause of mortality worldwide. Despite much development in the area of drug …
Multi-target natural products as alternatives against oxidative stress in Chronic Obstructive Pulmonary Disease (COPD)
PB Gonçalves, NC Romeiro - European journal of medicinal chemistry, 2019 - Elsevier
Abstract Chronic Obstructive Pulmonary Disease (COPD) is a major global health problem.
Among other conditions, it has been associated with chronic airway and lung parenchyma …
Among other conditions, it has been associated with chronic airway and lung parenchyma …
The mechanism of mitochondrial injury in alpha-1 antitrypsin deficiency mediated liver disease
N Khodayari, RL Wang, R Oshins, Y Lu… - International Journal of …, 2021 - mdpi.com
Alpha-1 antitrypsin deficiency (AATD) is caused by a single mutation in the SERPINA1 gene,
which culminates in the accumulation of misfolded alpha-1 antitrypsin (ZAAT) within the …
which culminates in the accumulation of misfolded alpha-1 antitrypsin (ZAAT) within the …
Results of a diagnostic procedure based on multiplex technology on dried blood spots and buccal swabs for subjects with suspected alpha1 antitrypsin deficiency
JL Lopez-Campos, F Casas-Maldonado… - Archivos de …, 2021 - Elsevier
Introduction The objective of this analysis was the evaluation of a new national circuit used
for diagnosing alpha1 antitrypsin deficiency (AATD) based on multiplex technology using …
for diagnosing alpha1 antitrypsin deficiency (AATD) based on multiplex technology using …